{
  "$schema": "folio-library-document/v1",
  "id": "10665-69096",
  "title": "Pre-qualification of single-use injection devices under the PQS system : a guideline for manufacturers",
  "variant": "pdf",
  "pages": 23,
  "tocSource": "outline",
  "tocMethod": null,
  "toc": [
    {
      "level": 1,
      "title": "Glossary",
      "number": null,
      "page": 3,
      "pageLabel": "3",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-000-glossary"
    },
    {
      "level": 1,
      "title": "Background",
      "number": "2.0",
      "page": 4,
      "pageLabel": "4",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-001-20-background"
    },
    {
      "level": 1,
      "title": "Procedural guide",
      "number": "3.0",
      "page": 4,
      "pageLabel": "4",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-002-30-procedural-guide"
    },
    {
      "level": 2,
      "title": "What is the PQS system?",
      "number": "3.1",
      "page": 4,
      "pageLabel": "4",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-003-31-what-is-the-pqs-system"
    },
    {
      "level": 2,
      "title": "Transitional arrangements for syringes for fixed dose im",
      "number": "3.2",
      "page": 5,
      "pageLabel": "5",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-004-32-transitional-arrangements-for-syringes-for-fi"
    },
    {
      "level": 2,
      "title": "Pre-qualification of syringes for general purpose use",
      "number": "3.3",
      "page": 5,
      "pageLabel": "5",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-005-33-pre-qualification-of-syringes-for-general-pur"
    },
    {
      "level": 2,
      "title": "What does PQS pre-qualification mean?",
      "number": "3.4",
      "page": 5,
      "pageLabel": "5",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-006-34-what-does-pqs-pre-qualification-mean"
    },
    {
      "level": 2,
      "title": "What products are eligible for pre-qualification?",
      "number": "3.5",
      "page": 6,
      "pageLabel": "6",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-007-35-what-products-are-eligible-for-pre-qualificat"
    },
    {
      "level": 2,
      "title": "What are the minimum licensing requirements?",
      "number": "3.6",
      "page": 6,
      "pageLabel": "6",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-008-36-what-are-the-minimum-licensing-requirements"
    },
    {
      "level": 2,
      "title": "How do I apply for pre-qualification?",
      "number": "3.7",
      "page": 7,
      "pageLabel": "7",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-009-37-how-do-i-apply-for-pre-qualification"
    },
    {
      "level": 2,
      "title": "How do I prepare a product dossier?",
      "number": "3.8",
      "page": 8,
      "pageLabel": "8",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-010-38-how-do-i-prepare-a-product-dossier"
    },
    {
      "level": 2,
      "title": "How much will I pay?",
      "number": "3.9",
      "page": 10,
      "pageLabel": "10",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-011-39-how-much-will-i-pay"
    },
    {
      "level": 2,
      "title": "The dossier evaluation process",
      "number": "3.10",
      "page": 10,
      "pageLabel": "10",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-012-310-the-dossier-evaluation-process"
    },
    {
      "level": 2,
      "title": "Evaluation results and the approval process",
      "number": "3.11",
      "page": 10,
      "pageLabel": "10",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-013-311-evaluation-results-and-the-approval-process"
    },
    {
      "level": 2,
      "title": "Maintaining pre-qualified status",
      "number": "3.12",
      "page": 11,
      "pageLabel": "11",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-014-312-maintaining-pre-qualified-status"
    },
    {
      "level": 2,
      "title": "The extra-ordinary PQS review process",
      "number": "3.12.1",
      "page": 11,
      "pageLabel": "11",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-015-3121-the-extra-ordinary-pqs-review-process"
    },
    {
      "level": 2,
      "title": "The annual PQS review process",
      "number": "3.12.2",
      "page": 11,
      "pageLabel": "11",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-016-3122-the-annual-pqs-review-process"
    },
    {
      "level": 2,
      "title": "Loosing pre-qualified status",
      "number": "3.13",
      "page": 12,
      "pageLabel": "12",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-017-313-loosing-pre-qualified-status"
    },
    {
      "level": 1,
      "title": "Checklists",
      "number": "4.0",
      "page": 13,
      "pageLabel": "13",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-018-40-checklists"
    },
    {
      "level": 2,
      "title": "Preliminary application checklist",
      "number": "4.1",
      "page": 13,
      "pageLabel": "13",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-019-41-preliminary-application-checklist"
    },
    {
      "level": 2,
      "title": "Dossier submission checklist",
      "number": "4.2",
      "page": 14,
      "pageLabel": "14",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-020-42-dossier-submission-checklist"
    },
    {
      "level": 2,
      "title": "Annual review checklist",
      "number": "4.3",
      "page": 15,
      "pageLabel": "15",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-021-43-annual-review-checklist"
    },
    {
      "level": 1,
      "title": "Annexes",
      "number": "5.0",
      "page": 16,
      "pageLabel": "16",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-022-50-annexes"
    },
    {
      "level": 2,
      "title": "Annex 5.1 - Definitions",
      "number": null,
      "page": 16,
      "pageLabel": "16",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-023-annex-51---definitions"
    },
    {
      "level": 2,
      "title": "Annex 5.2 – Standard Terms and Conditions",
      "number": null,
      "page": 18,
      "pageLabel": "18",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-024-annex-52-standard-terms-and-conditions"
    },
    {
      "level": 2,
      "title": "Annex 5.3 – Product Summary Sheet Questionnaire and instruct",
      "number": null,
      "page": 20,
      "pageLabel": "20",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-025-annex-53-product-summary-sheet-questionnaire-and"
    },
    {
      "level": 1,
      "title": "References",
      "number": "6.0",
      "page": 22,
      "pageLabel": "22",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-026-60-references"
    },
    {
      "level": 1,
      "title": "REVISION HISTORY FORM",
      "number": null,
      "page": 23,
      "pageLabel": "23",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-027-revision-history-form"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 3,
      "labelStart": "1",
      "labelEnd": "3",
      "words": 196,
      "summary": {
        "text": "The title page and table of contents of WHO's June 2005 guideline for manufacturers on pre-qualification of single-use injection devices under the PQS (Performance, Quality, Safety) system.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pqs review",
          "heading": false
        },
        {
          "term": "pqs system",
          "heading": false
        },
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "pre-qualification",
          "heading": false
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "pre-qualified status",
          "heading": false
        }
      ],
      "extract": "Pre-qualification of single-use injection devices under the PQS system: A guideline for manufacturers June 2005 Table of contents Glossary .........................................................................................................................3 2.0 Background....................................................................................................4 3.0 Procedural guide",
      "extractCut": true,
      "blocks": [
        "library/10665-69096/blocks/prose-sec-front-matter"
      ]
    },
    {
      "id": "sec-000-glossary",
      "number": null,
      "title": "Glossary",
      "level": 1,
      "pageStart": 3,
      "pageEnd": 4,
      "labelStart": "3",
      "labelEnd": "4",
      "words": 193,
      "summary": {
        "text": "A glossary of acronyms used in the PQS guideline, such as AD syringe, GHTF, GMP and ISO, followed by the start of the introduction. The introduction explains that the guideline tells manufacturers how to apply to WHO for pre-qualification of single-use injection devices and how to keep or lose that status.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "pqs system",
          "heading": false
        },
        {
          "term": "pre-qualification",
          "heading": false
        },
        {
          "term": "united nations",
          "heading": false
        },
        {
          "term": "procurement",
          "heading": false
        },
        {
          "term": "devices",
          "heading": false
        },
        {
          "term": "fund",
          "heading": false
        }
      ],
      "extract": "AD Auto-disable (syringe) ATT Access to Technologies (WHO team of Immunization, Vaccines & Biologicals Department) EU European Union EXW Ex Works (Incoterm) GHTF Global Harmonization Task Force GMP Good Manufacturing Practices IAPSO Inter-Agency Procurement Services Office (UN agency) ISO International Standards Organization PIS Product Information Sheets PQS Performance, Quality, Safety QA Quality Assurance RPF",
      "extractCut": true
    },
    {
      "id": "sec-001-20-background",
      "number": "2.0",
      "title": "Background",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": "4",
      "labelEnd": "4",
      "words": 215,
      "summary": {
        "text": "Explains why WHO recommends single-use injection devices, including auto-disable syringes, for infection control, and recalls the joint UNFPA, UNICEF and WHO statement that only auto-disable syringes should be used for immunization from 2003. It describes the roles of UN agencies and the medical device industry in securing a reliable supply.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "syringes",
          "heading": false
        },
        {
          "term": "auto-disable",
          "heading": false
        },
        {
          "term": "health care",
          "heading": false
        },
        {
          "term": "immunization",
          "heading": false
        },
        {
          "term": "designed",
          "heading": false
        }
      ],
      "extract": "In order to achieve effective infection control for intradermal, subcutaneous and intramuscular needle injections, WHO recommends the use of single-use injection devices. Single-use injection devices include single-use syringes used in conjunction with single-use needles, auto-disable (AD) syringes originally designed specifically for immunization, and syringes with a reuse-prevention feature for general purpose. In",
      "extractCut": true
    },
    {
      "id": "sec-002-30-procedural-guide",
      "number": "3.0",
      "title": "Procedural guide",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": "4",
      "labelEnd": "4",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-003-31-what-is-the-pqs-system",
      "number": "3.1",
      "title": "What is the PQS system?",
      "level": 2,
      "pageStart": 4,
      "pageEnd": 5,
      "labelStart": "4",
      "labelEnd": "5",
      "words": 240,
      "summary": {
        "text": "Describes the PQS system's origins in the WHO/UNICEF Product Information Sheets, used since 1979 to specify and test immunization equipment. It explains that conforming products will be listed as pre-qualified in an online database and catalogue.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pqs system",
          "heading": true
        },
        {
          "term": "pis",
          "heading": false
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "performance specifications",
          "heading": false
        },
        {
          "term": "immunization-related",
          "heading": false
        },
        {
          "term": "test procedures",
          "heading": false
        },
        {
          "term": "conform",
          "heading": false
        },
        {
          "term": "sheets",
          "heading": false
        }
      ],
      "extract": "What is the PQS system? Since 1979 WHO, in collaboration with UNICEF Supply Division, have developed and maintained a series of performance specifications and test procedures for 1 World Health Organization. WHO-UNICEF-UNFPA Joint statement on the use of auto-disable syringes in immunization services, 1999. WHO document WHO/V&B/99.25. Available from URL: http://www.who.int/vaccines-documents/DocsPDF99/www9948.pdf",
      "extractCut": true
    },
    {
      "id": "sec-004-32-transitional-arrangements-for-syringes-for-fi",
      "number": "3.2",
      "title": "Transitional arrangements for syringes for fixed dose im",
      "level": 2,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": "5",
      "labelEnd": "5",
      "words": 92,
      "summary": {
        "text": "Explains transitional arrangements: from 30 June 2005 UN agencies will in principle buy only devices pre-qualified under the new procedure, with auto-disable and reuse-prevention syringes required to meet the relevant ISO 7886 standards.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "fixed dose",
          "heading": true
        },
        {
          "term": "syringes",
          "heading": true
        },
        {
          "term": "transitional",
          "heading": true
        }
      ],
      "extract": "Transitional arrangements for syringes for fixed dose immunization and syringes with a reuse prevention feature By the 30 June 2005 single-use injection devices previously listed in the PIS will, in principle, no longer be procured by United Nations agencies unless the new pre- qualification procedure, described in this document, has been completed. Under the new procedure, auto-disable (AD) syringes for fixed dose",
      "extractCut": true
    },
    {
      "id": "sec-005-33-pre-qualification-of-syringes-for-general-pur",
      "number": "3.3",
      "title": "Pre-qualification of syringes for general purpose use",
      "level": 2,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": "5",
      "labelEnd": "5",
      "words": 72,
      "summary": {
        "text": "States that only auto-disable and reuse-prevention syringes will be pre-qualified at first, with therapeutic and insulin devices to be considered in July 2006.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "syringes",
          "heading": true
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "pqs",
          "heading": false
        }
      ],
      "extract": "Pre-qualification of syringes for general purpose use In the first stage of implementation of the PQS only AD syringes for fixed dose immunization and syringes with a reuse-prevention feature will be prequalified under the PQS system. The PQS Steering Group will, in consultation with partners and industry consider the prequalification of therapeutic single-use devices and insulin injection devices in July 2006 (one",
      "extractCut": true
    },
    {
      "id": "sec-006-34-what-does-pqs-pre-qualification-mean",
      "number": "3.4",
      "title": "What does PQS pre-qualification mean?",
      "level": 2,
      "pageStart": 5,
      "pageEnd": 6,
      "labelStart": "5",
      "labelEnd": "6",
      "words": 208,
      "summary": {
        "text": "Explains what pre-qualification means: it shows a device is technically suitable for UN procurement but does not guarantee purchase. Purchasers may add their own specifications, which must not conflict with ISO standards.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pqs pre-qualification",
          "heading": true
        },
        {
          "term": "pqs system",
          "heading": false
        },
        {
          "term": "purchaser",
          "heading": false
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "mean",
          "heading": true
        },
        {
          "term": "procurement",
          "heading": false
        }
      ],
      "extract": "What does PQS pre-qualification mean? As noted in paragraph 3.2, injection devices currently listed under the PIS system will, in principle, not longer be purchased by UN procurement agencies after 30 June 2005, unless they have been pre-qualified under the PQS system. 2 The 2000 edition of the Product information Sheets can be downloaded from the WHO website at: www.who.int/vaccines-documents/DocsPDF00/www518.pdf",
      "extractCut": true
    },
    {
      "id": "sec-007-35-what-products-are-eligible-for-pre-qualificat",
      "number": "3.5",
      "title": "What products are eligible for pre-qualification?",
      "level": 2,
      "pageStart": 6,
      "pageEnd": 6,
      "labelStart": "6",
      "labelEnd": "6",
      "words": 211,
      "summary": {
        "text": "Defines which syringes are eligible for pre-qualification, requiring compliance with specific ISO standards for therapeutic, fixed-dose immunization and insulin syringes. It notes that needles are not yet covered as a separate category.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pre-qualification",
          "heading": true
        },
        {
          "term": "hypodermic needles",
          "heading": false
        },
        {
          "term": "iso standards",
          "heading": false
        },
        {
          "term": "insulin injection",
          "heading": false
        },
        {
          "term": "syringes",
          "heading": false
        },
        {
          "term": "eligible",
          "heading": true
        }
      ],
      "extract": "What products are eligible for pre-qualification? Devices that conform to one of the two categories described in this section are potentially eligible for pre-qualification. Compliance with one of the two listed ISO standards is mandatory. Devices that only conform to national or regional standards are not eligible even if they do comply with the licensing and/or quality system standards set out in section 3.6.",
      "extractCut": true
    },
    {
      "id": "sec-008-36-what-are-the-minimum-licensing-requirements",
      "number": "3.6",
      "title": "What are the minimum licensing requirements?",
      "level": 2,
      "pageStart": 6,
      "pageEnd": 7,
      "labelStart": "6",
      "labelEnd": "7",
      "words": 374,
      "summary": {
        "text": "Sets out minimum licensing requirements: devices licensed in a founding member of the Global Harmonization Task Force meet the quality criteria, while others must show conformity with listed quality system standards. Evidence must come from an accredited certification body as certified copies.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ghtf founding",
          "heading": false
        },
        {
          "term": "founding member",
          "heading": false
        },
        {
          "term": "five ghtf",
          "heading": false
        },
        {
          "term": "device license",
          "heading": false
        },
        {
          "term": "licensing requirements",
          "heading": true
        },
        {
          "term": "party accredited",
          "heading": false
        },
        {
          "term": "documentary evidence",
          "heading": false
        },
        {
          "term": "market clearance",
          "heading": false
        }
      ],
      "extract": "What are the minimum licensing requirements? If a device is licensed in the territory of one of the founding members of the Global Harmonization Task Force (GHTF)3, it meets the minimum quality criteria required under the PQS pre-qualification procedure (Option 1 below). If the device is not 3 The founding members of the GHTF are Australia, Canada, the European Union, Japan and the United States. Pre-qualification",
      "extractCut": true
    },
    {
      "id": "sec-009-37-how-do-i-apply-for-pre-qualification",
      "number": "3.7",
      "title": "How do I apply for pre-qualification?",
      "level": 2,
      "pageStart": 7,
      "pageEnd": 8,
      "labelStart": "7",
      "labelEnd": "8",
      "words": 341,
      "summary": {
        "text": "Explains how to apply for pre-qualification by sending an introductory letter to the PQS Secretariat describing devices, standards and licensing, with 20 samples per device and site. WHO then either invites a formal application or advises that a device is unsuitable.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pre-qualification",
          "heading": true
        },
        {
          "term": "pqs secretariat",
          "heading": false
        },
        {
          "term": "introductory letter",
          "heading": false
        },
        {
          "term": "manufacturing site",
          "heading": false
        },
        {
          "term": "device",
          "heading": false
        },
        {
          "term": "qualification",
          "heading": false
        },
        {
          "term": "write",
          "heading": false
        },
        {
          "term": "send",
          "heading": false
        }
      ],
      "extract": "How do I apply for pre-qualification? You should send an introductory letter, by airmail, surface mail or courier service, to the PQS Secretariat at WHO, Geneva, giving the following information: 4 New, proposed legislation. Pre-qualification of single-use injection devices under the PQS system: A guideline for manufacturers launched 30 June 2005 8 of 23 • describe the devices that you have to offer and give the",
      "extractCut": true
    },
    {
      "id": "sec-010-38-how-do-i-prepare-a-product-dossier",
      "number": "3.8",
      "title": "How do I prepare a product dossier?",
      "level": 2,
      "pageStart": 8,
      "pageEnd": 10,
      "labelStart": "8",
      "labelEnd": "10",
      "words": 541,
      "summary": {
        "text": "Explains how to prepare a product dossier, requiring a separate dossier for each device type, syringe volume and manufacturing site. It lists the required contents and the address for submission.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "product dossier",
          "heading": true
        },
        {
          "term": "certified photocopies",
          "heading": false
        },
        {
          "term": "injection device",
          "heading": false
        },
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "pqs system",
          "heading": false
        },
        {
          "term": "manufacturing site",
          "heading": false
        },
        {
          "term": "pre-qualification",
          "heading": false
        },
        {
          "term": "launched june",
          "heading": false
        }
      ],
      "extract": "How do I prepare a product dossier? You must submit a separate and complete product dossier for each type of device that you have offered and which we have accepted as being suitable for evaluation. One dossier is required for each volume of syringe (for example, if you submit 1 ml, 2 ml and 5 ml syringes we will require three dossiers). If you are offering a syringe that is manufactured at more than one",
      "extractCut": true
    },
    {
      "id": "sec-011-39-how-much-will-i-pay",
      "number": "3.9",
      "title": "How much will I pay?",
      "level": 2,
      "pageStart": 10,
      "pageEnd": 10,
      "labelStart": "10",
      "labelEnd": "10",
      "words": 112,
      "summary": {
        "text": "Sets out cost-recovery fees for 2005: US$ 1000 for dossier examination and US$ 700 for each annual re-evaluation, charged per device.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "re-evaluation fee",
          "heading": false
        },
        {
          "term": "fee scale",
          "heading": false
        },
        {
          "term": "annual re-evaluation",
          "heading": false
        }
      ],
      "extract": "How much will I pay? We will charge you on a cost recovery basis for the initial evaluation of your dossier. If your device is pre-qualified you will also be required to pay an annual re-evaluation fee as described in 3.11.2. The current fee scale, which will remain fixed until 31 December 2005, is shown in Table 3. (WHO will review the fee scale at the end of 2005). Table 3 - Cost recovery fees to be paid to WHO",
      "extractCut": true
    },
    {
      "id": "sec-012-310-the-dossier-evaluation-process",
      "number": "3.10",
      "title": "The dossier evaluation process",
      "level": 2,
      "pageStart": 10,
      "pageEnd": 10,
      "labelStart": "10",
      "labelEnd": "10",
      "words": 197,
      "summary": {
        "text": "Describes the dossier evaluation process, including a one-month grace period for missing items, possible use of independent evaluators under confidentiality, and acceptance of ISO-compliant devices without further testing.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "dossier",
          "heading": true
        },
        {
          "term": "dossier fee",
          "heading": false
        },
        {
          "term": "dossier examination",
          "heading": false
        },
        {
          "term": "evaluation process",
          "heading": true
        },
        {
          "term": "supplied",
          "heading": false
        }
      ],
      "extract": "The dossier evaluation process We will review the contents of your dossier. If anything is missing we will contact you in writing giving you a period of one month to provide the missing information, dossier fee or samples. If you fail to respond by the end of this period of grace we will return your dossier; the dossier examination fee will not be refunded. In addition we will not evaluate your dossier until the",
      "extractCut": true
    },
    {
      "id": "sec-013-311-evaluation-results-and-the-approval-process",
      "number": "3.11",
      "title": "Evaluation results and the approval process",
      "level": 2,
      "pageStart": 10,
      "pageEnd": 11,
      "labelStart": "10",
      "labelEnd": "11",
      "words": 193,
      "summary": {
        "text": "Describes how evaluation results are reviewed and decided by the PQS Steering Group within six weeks of a complete dossier, and how manufacturers are told of approval or rejection, with decisions final.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pqs",
          "heading": false
        },
        {
          "term": "evaluation",
          "heading": true
        },
        {
          "term": "process",
          "heading": true
        },
        {
          "term": "dossier",
          "heading": false
        },
        {
          "term": "approval",
          "heading": true
        }
      ],
      "extract": "Evaluation results and the approval process The PQS Secretariat will monitor the evaluation process and will endeavour to process applications as rapidly as resources allow; it will receive and review the evaluation results. The PQS Steering Group makes all final decisions on pre- qualification. WHO commit to a time limit of six weeks for the process from receipt of a complete dossier. The clock will stop if a",
      "extractCut": true
    },
    {
      "id": "sec-014-312-maintaining-pre-qualified-status",
      "number": "3.12",
      "title": "Maintaining pre-qualified status",
      "level": 2,
      "pageStart": 11,
      "pageEnd": 11,
      "labelStart": "11",
      "labelEnd": "11",
      "words": 82,
      "summary": {
        "text": "States that pre-qualified products are kept under continual review and that manufacturers must report significant changes to product, process or site or risk losing their status.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pre-qualified status",
          "heading": true
        },
        {
          "term": "manufacturing",
          "heading": false
        },
        {
          "term": "maintaining",
          "heading": true
        }
      ],
      "extract": "Maintaining pre-qualified status The performance of your product and of your company will be kept under continual review through the formal PQS review procedure and throughout the procurement process at the various UN procurement agencies. It is essential that you keep us fully informed about any significant change you make to the specifications of the product, to the manufacturing process or to the manufacturing",
      "extractCut": true
    },
    {
      "id": "sec-015-3121-the-extra-ordinary-pqs-review-process",
      "number": "3.12.1",
      "title": "The extra-ordinary PQS review process",
      "level": 2,
      "pageStart": 11,
      "pageEnd": 11,
      "labelStart": "11",
      "labelEnd": "11",
      "words": 89,
      "summary": {
        "text": "Describes extraordinary reviews when serious problems such as adverse events or device failures arise, which may lead to suspension or withdrawal of pre-qualification.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pre-qualification status",
          "heading": false
        },
        {
          "term": "receivership",
          "heading": false
        },
        {
          "term": "suspend",
          "heading": false
        }
      ],
      "extract": "If serious problems arise with the product, leading to vigilance reporting, we reserve the right to re-evaluate your pre-qualification status at any time. A serious problem is an adverse event, device failure or other circumstance requiring immediate action. Generally, we will tell you about the problem and ask you to resolve it by an agreed date. However, if the problem is severe, we may suspend your",
      "extractCut": true
    },
    {
      "id": "sec-016-3122-the-annual-pqs-review-process",
      "number": "3.12.2",
      "title": "The annual PQS review process",
      "level": 2,
      "pageStart": 11,
      "pageEnd": 12,
      "labelStart": "11",
      "labelEnd": "12",
      "words": 407,
      "summary": {
        "text": "Describes the annual review of pre-qualified devices against a standard checklist, with manufacturers required to pay the re-evaluation fee and submit renewed documents on time. Results are communicated only if problems are found or status changes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "annual review",
          "heading": true
        },
        {
          "term": "pqs",
          "heading": true
        },
        {
          "term": "annual re-evaluation",
          "heading": false
        },
        {
          "term": "certified copy",
          "heading": false
        },
        {
          "term": "pre qualification",
          "heading": false
        },
        {
          "term": "fixed time",
          "heading": false
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "single fixed",
          "heading": false
        }
      ],
      "extract": "All PQS pre-qualified injection devices will be reviewed once a year at a single fixed time, that will be communicated to you at the time prequalification is granted, against a standard checklist based on Annex 4.3. The annual review process will consider all relevant aspects of your device, including those referred to in Section 3.12. If we have previously highlighted problems which you need to resolve by an agreed",
      "extractCut": true
    },
    {
      "id": "sec-017-313-loosing-pre-qualified-status",
      "number": "3.13",
      "title": "Loosing pre-qualified status",
      "level": 2,
      "pageStart": 12,
      "pageEnd": 13,
      "labelStart": "12",
      "labelEnd": "13",
      "words": 231,
      "summary": {
        "text": "Lists the ways a manufacturer can lose pre-qualified status, such as unapproved changes to site, process or specification, poor quality reports from UN agencies, failure to report adverse events or renew licences, and bankruptcy.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pre-qualified",
          "heading": true
        },
        {
          "term": "clause",
          "heading": false
        },
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "loosing",
          "heading": true
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "fail",
          "heading": false
        }
      ],
      "extract": "Loosing pre-qualified status There are several ways in which you could loose your status as a pre-qualified manufacturer. These include, but are not confined to, the following: • if you change the manufacturing site with or without notifying us of your intention to do so (Annex 5.2, clause 8); • if you change the manufacturing process in an unacceptable way (one that negatively effects the performance of the device)",
      "extractCut": true
    },
    {
      "id": "sec-018-40-checklists",
      "number": "4.0",
      "title": "Checklists",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 13,
      "labelStart": "13",
      "labelEnd": "13",
      "words": 26,
      "summary": {
        "text": "Introduces three checklists to help manufacturers submit the information needed at each stage of pre-qualification.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "This section provides you with three checklists designed to ensure that you send us all the information that we require at each of the stages specified.",
      "extractCut": false
    },
    {
      "id": "sec-019-41-preliminary-application-checklist",
      "number": "4.1",
      "title": "Preliminary application checklist",
      "level": 2,
      "pageStart": 13,
      "pageEnd": 14,
      "labelStart": "13",
      "labelEnd": "14",
      "words": 150,
      "summary": {
        "text": "A checklist for the preliminary application, covering the covering letter, device descriptions, site details, standards, licensing and samples.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "preliminary application",
          "heading": true
        },
        {
          "term": "manufacturing site",
          "heading": false
        },
        {
          "term": "device",
          "heading": false
        },
        {
          "term": "labelled",
          "heading": false
        }
      ],
      "extract": "Preliminary application checklist Refer to Section 3.7 - Have you included the following? 1. A covering letter.  2. A description of each device that you wish to offer for evaluation.  3. Brief details of each of your manufacturing sites.  4. Confirmation of the production capacity of each of your manufacturing sites.  5. A list of the standards to which each device conforms.  6. A brief description of the",
      "extractCut": true
    },
    {
      "id": "sec-020-42-dossier-submission-checklist",
      "number": "4.2",
      "title": "Dossier submission checklist",
      "level": 2,
      "pageStart": 14,
      "pageEnd": 15,
      "labelStart": "14",
      "labelEnd": "15",
      "words": 333,
      "summary": {
        "text": "A checklist for dossier submission, covering the invitation letter, dossier fee, product summary questionnaire and supporting evidence such as regulatory approvals and certificates, with one dossier per device and site.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "certified photocopies",
          "heading": false
        },
        {
          "term": "dossier",
          "heading": true
        },
        {
          "term": "manufacturing site",
          "heading": false
        },
        {
          "term": "device",
          "heading": false
        },
        {
          "term": "million units",
          "heading": false
        },
        {
          "term": "regulatory approval",
          "heading": false
        },
        {
          "term": "submission",
          "heading": true
        },
        {
          "term": "product",
          "heading": false
        }
      ],
      "extract": "Dossier submission checklist Refer to Section 3.8 - Have you included the following items for each device and for each manufacturing site? 1. A covering letter.  2. A countersigned copy of the letter of invitation received from WHO  3. The correct Dossier Examination Fee, in US dollars.  4. Completed Product Summary Sheet Questionnaire supported by the following material:  • Confirmation that you are the Legal",
      "extractCut": true
    },
    {
      "id": "sec-021-43-annual-review-checklist",
      "number": "4.3",
      "title": "Annual review checklist",
      "level": 2,
      "pageStart": 15,
      "pageEnd": 16,
      "labelStart": "15",
      "labelEnd": "16",
      "words": 287,
      "summary": {
        "text": "A checklist for the annual review, covering the re-evaluation fee, renewed licences and certificates and details of changes to sites, processes or specifications.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "certified photocopy",
          "heading": false
        },
        {
          "term": "manufacturing site",
          "heading": false
        },
        {
          "term": "annual",
          "heading": true
        },
        {
          "term": "submission",
          "heading": false
        },
        {
          "term": "past year",
          "heading": false
        },
        {
          "term": "device",
          "heading": false
        },
        {
          "term": "dossier",
          "heading": false
        }
      ],
      "extract": "Annual review checklist Refer to Section 3.12.2 - Have you included the following items for each pre- qualified device and for each manufacturing site? 1. A covering letter specifying the device to which the dossier refers.  2. The annual re-evaluation fee in US dollars.  3. Certified photocopy of your annual license renewal(s) if the current license(s) is/are due to expire before the review meeting.  4.",
      "extractCut": true
    },
    {
      "id": "sec-022-50-annexes",
      "number": "5.0",
      "title": "Annexes",
      "level": 1,
      "pageStart": 16,
      "pageEnd": 16,
      "labelStart": "16",
      "labelEnd": "16",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-023-annex-51---definitions",
      "number": null,
      "title": "Annex 5.1 - Definitions",
      "level": 2,
      "pageStart": 16,
      "pageEnd": 18,
      "labelStart": "16",
      "labelEnd": "18",
      "words": 511,
      "summary": {
        "text": "Annex 5.1 giving definitions used in the PQS guideline, such as adverse event, certification body, certified copy and device, with some definitions derived from EU directives and ISO standards.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "unit container",
          "heading": false
        },
        {
          "term": "secondary container",
          "heading": false
        },
        {
          "term": "storage container",
          "heading": false
        },
        {
          "term": "primary container",
          "heading": false
        },
        {
          "term": "injection device",
          "heading": false
        },
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "certified copy",
          "heading": false
        },
        {
          "term": "legal manufacturer",
          "heading": false
        }
      ],
      "extract": "The following definitions apply to this document: Adverse event An incident resulting in permanent impairment, hospitalization, congenital malformation, injury or death to patients or users of a single-use injection device. Certification Body A Certification Body is a government department or agency or a third party organization that provides services for conformity assessment following completion of an independent",
      "extractCut": true
    },
    {
      "id": "sec-024-annex-52-standard-terms-and-conditions",
      "number": null,
      "title": "Annex 5.2 – Standard Terms and Conditions",
      "level": 2,
      "pageStart": 18,
      "pageEnd": 20,
      "labelStart": "18",
      "labelEnd": "20",
      "words": 1377,
      "summary": {
        "text": "Annex 5.2 setting out the standard terms and conditions for pre-qualification of single-use injection devices, which all manufacturers must follow. Clauses cover dossier screening, non-refundable fees, ongoing reporting of changes and adverse events, and grounds for suspension or withdrawal. Definitions of packaging terms such as unit container close the annex.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "injection device",
          "heading": false
        },
        {
          "term": "pqs products",
          "heading": false
        },
        {
          "term": "pqs database",
          "heading": false
        },
        {
          "term": "device failure",
          "heading": false
        },
        {
          "term": "unit container",
          "heading": false
        },
        {
          "term": "product dossiers",
          "heading": false
        },
        {
          "term": "pqs website",
          "heading": false
        }
      ],
      "extract": "The Terms and Conditions and Definitions set out below will apply to all manufacturers of PQS pre-qualified injection devices. You should familiarize yourself with this document and ensure that you comply fully with the on-going reporting requirements set out therein. Failure to do so may result in the suspension or withdrawal of your pre-qualification status. TERMS AND CONDITIONS FOR THE PRE-QUALIFICATION OF",
      "extractCut": true
    },
    {
      "id": "sec-025-annex-53-product-summary-sheet-questionnaire-and",
      "number": null,
      "title": "Annex 5.3 – Product Summary Sheet Questionnaire and instruct",
      "level": 2,
      "pageStart": 20,
      "pageEnd": 22,
      "labelStart": "20",
      "labelEnd": "22",
      "words": 681,
      "summary": {
        "text": "Annex 5.3, the product summary sheet questionnaire to be completed for each product and site, with instructions. It asks for device and vendor details, regulatory licences in GHTF countries, quality system certificates, test certificates and post-market surveillance reports.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "product summary",
          "heading": true
        },
        {
          "term": "device name",
          "heading": false
        },
        {
          "term": "summary sheet",
          "heading": true
        },
        {
          "term": "brand name",
          "heading": false
        },
        {
          "term": "check applicable",
          "heading": false
        },
        {
          "term": "ghtf founding",
          "heading": false
        },
        {
          "term": "manufacturing site",
          "heading": false
        },
        {
          "term": "product standards",
          "heading": false
        }
      ],
      "extract": "Information item INJECTION DEVICE PRODUCT SUMMARY SHEET (Complete one questionnaire per product and per manufacturing site – see note 1) 1  Device description 2  Brand name Remarks 3  Vendor status  Manufacturer  Wholesaler  Distributor  Other (specify) Name Address Phone and Fax Contact person for quality assurance Web-site, e-mail 4  Vendor  Manufacturer 5  Manufacturing Site 6  Parent company (if any)",
      "extractCut": true
    },
    {
      "id": "sec-026-60-references",
      "number": "6.0",
      "title": "References",
      "level": 1,
      "pageStart": 22,
      "pageEnd": 23,
      "labelStart": "22",
      "labelEnd": "23",
      "words": 231,
      "summary": {
        "text": "A list of references for the PQS guideline, citing ISO standards for needles and syringes and WHO documents on injection safety and the Product Information Sheets.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hypodermic syringes",
          "heading": false
        },
        {
          "term": "sterile hypodermic",
          "heading": false
        },
        {
          "term": "single-use injection",
          "heading": false
        },
        {
          "term": "bct",
          "heading": false
        },
        {
          "term": "injection devices",
          "heading": false
        },
        {
          "term": "guiding principles",
          "heading": false
        },
        {
          "term": "pqs",
          "heading": false
        },
        {
          "term": "iso",
          "heading": false
        }
      ],
      "extract": "ISO standards and WHO performance specifications: 1. ISO 7864:1993 Sterile hypodermic needles for single use. 2. ISO 7886-1:1993 Sterile hypodermic syringes for single use - Part 1: Syringes for manual use. 3. ISO 8537:1991 Sterile single-use syringes, with or without needle, for insulin. 4. ISO 7886-3: Sterile hypodermic syringes for single use – Part 3: Auto-disable syringes for fixed dose immunization 5. ISO DIS",
      "extractCut": true
    },
    {
      "id": "sec-027-revision-history-form",
      "number": null,
      "title": "REVISION HISTORY FORM",
      "level": 1,
      "pageStart": 23,
      "pageEnd": 23,
      "labelStart": "23",
      "labelEnd": "23",
      "words": 18,
      "summary": {
        "text": "A blank revision history form for the PQS guideline, with fields for dates, reasons and authorization.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "(Form number: FCH/IVB /ATT/GEN/F002) SOP Number Date of original version: REVISIONS Date Reason Authorized by (Signature and Name)",
      "extractCut": false
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 1,
        "items": [
          "– Product Summary Sheet Questionnaire and instructions"
        ]
      },
      "found_not_listed": {
        "count": 8,
        "items": [
          "1.0 Introduction",
          "3.2 Transitional arrangements for syringes for fixed dose immunization and syringes with a reuse prevention feature",
          "4.1 Preliminary application checklist Refer to Section 3.7 - Have you included the following?",
          "4.2 Dossier submission checklist Refer to Section 3.8 - Have you included the following items for each device and for each manufacturing site?",
          "4 ISO 7886-3: Sterile hypodermic syringes for single use – Part 3: Auto-disable syringes for fixed dose immunization",
          "1 WHO. A guide for the quality assurance of single-use injection equipment.",
          "2 WHO. Best infection control practices for intradermal, subcutaneous and intramuscular needle injections. WHO/BCT/DCT/01.02.",
          "6 WHO. Medical device regulations, global overview and guiding principles."
        ]
      },
      "page_mismatch": {
        "count": 0,
        "items": []
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "pqs pre-qualification",
      "heading": true
    },
    {
      "term": "injection device",
      "heading": false
    },
    {
      "term": "single-use injection",
      "heading": false
    },
    {
      "term": "pqs pre-qualified",
      "heading": false
    },
    {
      "term": "pqs system",
      "heading": true
    },
    {
      "term": "single-use syringes",
      "heading": false
    },
    {
      "term": "pqs products",
      "heading": false
    },
    {
      "term": "pqs review",
      "heading": true
    },
    {
      "term": "device license",
      "heading": false
    },
    {
      "term": "pqs secretariat",
      "heading": false
    },
    {
      "term": "pqs database",
      "heading": false
    },
    {
      "term": "pqs website",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "1",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "2",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "3",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 4,
      "label": "4",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 5,
      "label": "5",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 6,
      "label": "6",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 7,
      "label": "7",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 8,
      "label": "8",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 9,
      "label": "9",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 10,
      "label": "10",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 11,
      "label": "11",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 12,
      "label": "12",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 13,
      "label": "13",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 14,
      "label": "14",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 15,
      "label": "15",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 16,
      "label": "16",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 17,
      "label": "17",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 18,
      "label": "18",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 19,
      "label": "19",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 20,
      "label": "20",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 21,
      "label": "21",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 22,
      "label": "22",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 23,
      "label": "23",
      "source": "pdf-labels",
      "confidence": 0.85
    }
  ],
  "figures": [
    {
      "kind": "table",
      "number": "1",
      "title": "Licensing requirements in the five GHTF founding member countries",
      "page": 7,
      "pageLabel": "7",
      "confidence": 0.8,
      "evidence": [
        "referenced",
        "in-sequence"
      ]
    },
    {
      "kind": "table",
      "number": "2",
      "title": "Acceptable quality system standards in the five GHTF founding member countries",
      "page": 7,
      "pageLabel": "7",
      "confidence": 0.8,
      "evidence": [
        "referenced",
        "in-sequence"
      ]
    },
    {
      "kind": "table",
      "number": "3",
      "title": "Cost recovery fees to be paid to WHO (2005)",
      "page": 10,
      "pageLabel": "10",
      "confidence": 0.8,
      "evidence": [
        "referenced",
        "in-sequence"
      ]
    }
  ],
  "tables": [
    {
      "label": "Table 1",
      "caption": "Table 1 – Licensing requirements in the five GHTF founding member countries",
      "pages": [
        7
      ],
      "columns": [
        {
          "titles": ""
        },
        {
          "titles": "Australia ⁴"
        },
        {
          "titles": "Canada"
        },
        {
          "titles": "European Union"
        },
        {
          "titles": "Japan"
        },
        {
          "titles": "United States"
        }
      ],
      "rows": [
        [
          "Marketing permit/ condition",
          "GMPALS License or CE Mark",
          "Device license",
          "CE mark",
          "Device license",
          "510k device letter"
        ]
      ],
      "notes": "4 New, proposed legislation.",
      "narratives": {
        "en": "The table shows, for each of the five Global Harmonization Task Force (GHTF) founding member countries/areas (Australia, Canada, European Union, Japan, United States), the marketing permit or condition required for a medical device.",
        "ar": "يبيّن الجدول، لكل من البلدان/المناطق الخمسة المؤسِّسة لفرقة العمل المعنية بالمواءمة العالمية (أستراليا، كندا، الاتحاد الأوروبي، اليابان، الولايات المتحدة)، إذن التسويق أو الشرط المطلوب للجهاز الطبي.",
        "zh": "该表列出全球协调工作组五个创始成员国/地区（澳大利亚、加拿大、欧洲联盟、日本、美国）对医疗器械要求的上市许可或条件。",
        "es": "La tabla muestra, para cada uno de los cinco países/zonas miembros fundadores del Grupo de Trabajo de Armonización Mundial (GHTF) (Australia, Canadá, Unión Europea, Japón, Estados Unidos), el permiso o la condición de comercialización exigidos para un dispositivo médico.",
        "fr": "Le tableau indique, pour chacun des cinq pays/zones membres fondateurs du Groupe de travail sur l’harmonisation mondiale (GHTF) (Australie, Canada, Union européenne, Japon, États-Unis), l’autorisation ou la condition de mise sur le marché exigée pour un dispositif médical.",
        "ru": "В таблице для каждой из пяти стран/территорий — членов-учредителей Целевой группы по глобальной гармонизации (GHTF) (Австралия, Канада, Европейский союз, Япония, США) указаны разрешение на сбыт или условие, требуемые для медицинского изделия."
      },
      "csv": "tables/table-1.csv"
    },
    {
      "label": "Table 2",
      "caption": "Table 2 - Acceptable quality system standards in the five GHTF founding member countries",
      "pages": [
        7
      ],
      "columns": [
        {
          "titles": "Country"
        },
        {
          "titles": "Quality system standards for medical devices"
        },
        {
          "titles": "Certification body"
        }
      ],
      "rows": [
        [
          "Australia",
          "ISO13485 or ISO13488",
          "Government or third party accredited by the government"
        ],
        [
          "Canada",
          "ISO13485 or ISO13488",
          "Third party accredited by the government"
        ],
        [
          "European Union",
          "ISO13485 or ISO13488",
          "Notified Bodies"
        ],
        [
          "Japan",
          "GMP (QS Standard for medical devices #1128)",
          "Government"
        ],
        [
          "United States",
          "QS (21 CFR part 820)",
          "Government"
        ]
      ],
      "narratives": {
        "en": "For each of the five GHTF founding member countries/areas, the table lists the acceptable quality system standards for medical devices and the body that certifies compliance.",
        "ar": "يسرد الجدول، لكل من البلدان/المناطق الخمسة المؤسِّسة لفرقة العمل المعنية بالمواءمة العالمية، معايير نظام الجودة المقبولة للأجهزة الطبية والجهة التي تصدر شهادة الامتثال.",
        "zh": "该表针对全球协调工作组五个创始成员国/地区，列出可接受的医疗器械质量体系标准及认证合规的机构。",
        "es": "Para cada uno de los cinco países/zonas miembros fundadores del GHTF, la tabla enumera las normas de sistemas de calidad aceptables para los dispositivos médicos y el organismo que certifica su cumplimiento.",
        "fr": "Pour chacun des cinq pays/zones membres fondateurs du GHTF, le tableau énumère les normes de système qualité acceptables pour les dispositifs médicaux et l’organisme qui certifie la conformité.",
        "ru": "Для каждой из пяти стран/территорий — членов-учредителей GHTF в таблице перечислены приемлемые стандарты системы качества для медицинских изделий и орган, сертифицирующий соответствие."
      },
      "csv": "tables/table-2.csv"
    },
    {
      "label": "Table 3",
      "caption": "Table 3 - Cost recovery fees to be paid to WHO (2005)",
      "pages": [
        10
      ],
      "columns": [
        {
          "titles": "Step"
        },
        {
          "titles": "Fee to be paid to WHO"
        }
      ],
      "rows": [
        [
          "Dossier examination fee",
          "US$ 1,000"
        ],
        [
          "Annual re-evaluation fee",
          "US$ 700"
        ]
      ],
      "notes": "Note that these fees will be charged for each and every device you submit.",
      "narratives": {
        "en": "The table lists the two cost-recovery fees that manufacturers pay to WHO for pre-qualification of injection devices in 2005: the dossier examination fee and the annual re-evaluation fee.",
        "ar": "يسرد الجدول رسمَي استرداد التكاليف اللذين يدفعهما المصنّعون إلى منظمة الصحة العالمية للتأهيل المسبق لأجهزة الحقن في عام 2005: رسم فحص الملف ورسم إعادة التقييم السنوي.",
        "zh": "该表列出2005年制造商为注射器具预认证向世卫组织支付的两项成本回收费用：卷宗审查费和年度重新评估费。",
        "es": "La tabla enumera las dos tasas de recuperación de costos que los fabricantes pagan a la OMS por la precalificación de dispositivos de inyección en 2005: la tasa de examen del expediente y la tasa anual de reevaluación.",
        "fr": "Le tableau énumère les deux redevances de recouvrement des coûts versées à l’OMS par les fabricants pour la préqualification des dispositifs d’injection en 2005 : la redevance d’examen du dossier et la redevance annuelle de réévaluation.",
        "ru": "В таблице перечислены два сбора для возмещения затрат, которые производители уплачивают ВОЗ за предварительную квалификацию инъекционных устройств в 2005 г.: сбор за рассмотрение досье и ежегодный сбор за повторную оценку."
      },
      "csv": "tables/table-3.csv"
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 28,
      "note": "outline"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 29,
      "note": "2 levels"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "found",
      "count": 3
    },
    {
      "kind": "references",
      "state": "not-extracted",
      "note": "a references section is in the text (p22); its entries are not extracted"
    },
    {
      "kind": "glossary",
      "state": "not-extracted",
      "note": "a glossary section is in the text (p3); its entries are not extracted"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "partial",
      "count": 27,
      "note": "27 of 29 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-69096"
  }
}
